Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

GATA2 Deficiency × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9 Myeloid 6 Classical hematology 3 Lymphoid 2 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Multiple Myeloma 3186 Neoplasms, Plasma Cell 619 Lymphoma 472 Lymphoma, Non-Hodgkin 431 Leukemia, Lymphocytic, Chronic, B-Cell 361 Hodgkin Disease 358 Recurrence 351 Leukemia 337 Precursor Cell Lymphoblastic Leukemia-Lymphoma 329 Leukemia, Myeloid, Acute 318 Myelodysplastic Syndromes 297 Lymphoma, Mantle-Cell 253 Lymphoma, Large B-Cell, Diffuse 253 Lymphoma, Follicular 249 Lymphoma, B-Cell, Marginal Zone 222 Burkitt Lymphoma 217 Myeloproliferative Disorders 203 Lymphoma, Large-Cell, Immunoblastic 197 Immunoglobulin Light-chain Amyloidosis 197 Neoplasms 182 Hematologic Neoplasms 178 Primary Myelofibrosis 168 Leukemia, Myeloid, Chronic-Phase 157 Leukemia, Myeloid, Accelerated Phase 152 Lymphoma, T-Cell, Cutaneous 151 Blast Crisis 144 Leukemia, Myelomonocytic, Chronic 140 Waldenstrom Macroglobulinemia 138 Mycosis Fungoides 128 Sezary Syndrome 127

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03018405 2019-09-19

THINK

Celyad Oncology SA

Phase 1/2 Unknown

GATA2 Deficiency, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡